Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (Dern)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03923842
Recruitment Status : Unknown
Verified February 2020 by Gruppo Oncologico del Nord-Ovest.
Recruitment status was:  Recruiting
First Posted : April 23, 2019
Last Update Posted : February 17, 2020
Mario Negri Institute for Pharmacological Research
Information provided by (Responsible Party):
Gruppo Oncologico del Nord-Ovest

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 30, 2021
Estimated Study Completion Date : October 30, 2022